5TQ7
Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.2 |
Synchrotron site | ALS |
Beamline | 5.0.2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2008-02-02 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 1 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 37.061, 185.108, 52.492 |
Unit cell angles | 90.00, 110.64, 90.00 |
Refinement procedure
Resolution | 33.680 - 2.100 |
R-factor | 0.22891 |
Rwork | 0.226 |
R-free | 0.28575 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3tjc |
RMSD bond length | 0.013 |
RMSD bond angle | 1.693 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0135) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 33.680 |
High resolution limit [Å] | 2.100 |
Rmerge | 0.200 |
Number of reflections | 30766 |
<I/σ(I)> | 13.9 |
Completeness [%] | 71.0 |
Redundancy | 2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 7.5 | 293 | 0.1 M Hepes, pH 7.5, 100 mM sodium acetate, 30% PEG3350 |